Skip to main content

Showing results for Research Funding

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature blood cells, exhibit better responses in a low-oxygen environment within the bone marrow, also known as hypoxia.

IU School of Medicine  |  Apr 25, 2024

IU researchers receive $4.8 million grant to study the role of misfolded protein TDP-43 in neurodegenerative diseases

A new $4.8 million grant will support researchers from Indiana University School of Medicine and the Medical Research Council Laboratory of Molecular Biology to study how human neurodegenerative diseases are affected by the misfolding of the protein TDP-43.

IU School of Medicine  |  Apr 23, 2024

$4.7 million award to help researchers prevent adolescent alcohol use

Indiana University School of Medicine researchers recently were awarded $4.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to further the study of caregiver intervention in reducing adolescent alcohol use and other substance use disorders (SUDs).

IU School of Medicine  |  Apr 18, 2024

$1 million gift to support professorship focused on neuroscience innovation

Indiana University School of Medicine alum and renowned neurosurgeon Joseph Maroon, MD, has provided a $1 million gift to support a leader in research dedicated to neuroscience innovation.

IU School of Medicine  |  Mar 11, 2024

IU School of Medicine's 2023 NIH funding ranked No. 13 among public universities

Indiana University School of Medicine researchers received over $243 million in total funding from the National Institutes of Health during federal fiscal year 2023 — a more than $54 million increase over the past five years, or 28%.

IU School of Medicine  |  Feb 20, 2024

$3.4 million grant to fund research on brain bleeding, swelling that occurs in quarter of patients who receive Alzheimer’s disease treatments

With the emergence of promising treatments that slow the cognitive decline of Alzheimer’s disease in patients, there are still questions surrounding side effects of the drugs. An Indiana University School of Medicine researcher is among the few neuroscientists investigating these adverse events, which can cause brain swelling and brain bleeding.

IU School of Medicine  |  Feb 14, 2024

IU surgeon-scientist studying physiological effect of microorganisms in sinuses of chronic rhinosinusitis patients

An Indiana University School of Medicine surgeon-scientist is leading a multi-institutional grant investigating the role of the sinus microbiome in chronic rhinosinusitis, an inflammatory disease that causes the lining of the sinuses to swell.

IU School of Medicine  |  Feb 01, 2024

New research aims to develop novel therapeutic for glaucoma

INDIANAPOLIS—Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.

IU School of Medicine  |  Jan 04, 2024

Beta blocker used to treat heart problems and other medical concerns could be new treatment for sickle cell cardiomyopathy

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease.

IU School of Medicine  |  Jan 03, 2024

Lung cancer screenings to expand for Indiana veterans thanks to $1 million grant

Two researchers with the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the Richard L. Roudebush Veterans Administration Medical Center have been awarded a three-year, $1 million grant to expand lung cancer screenings to veterans across Indiana.

IU Simon Comprehensive Cancer Center  |  Dec 13, 2023